Cargando…
Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning
An improved approach for predicting the risk for incident coronary heart disease (CHD) could lead to substantial improvements in cardiovascular health. Previously, we have shown that genetic and epigenetic loci could predict CHD status more sensitively than conventional risk factors. Herein, we exam...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315411/ https://www.ncbi.nlm.nih.gov/pubmed/30567402 http://dx.doi.org/10.3390/genes9120641 |
_version_ | 1783384288061816832 |
---|---|
author | Dogan, Meeshanthini V. Beach, Steven R. H. Simons, Ronald L. Lendasse, Amaury Penaluna, Brandan Philibert, Robert A. |
author_facet | Dogan, Meeshanthini V. Beach, Steven R. H. Simons, Ronald L. Lendasse, Amaury Penaluna, Brandan Philibert, Robert A. |
author_sort | Dogan, Meeshanthini V. |
collection | PubMed |
description | An improved approach for predicting the risk for incident coronary heart disease (CHD) could lead to substantial improvements in cardiovascular health. Previously, we have shown that genetic and epigenetic loci could predict CHD status more sensitively than conventional risk factors. Herein, we examine whether similar machine learning approaches could be used to develop a similar panel for predicting incident CHD. Training and test sets consisted of 1180 and 524 individuals, respectively. Data mining techniques were employed to mine for predictive biosignatures in the training set. An ensemble of Random Forest models consisting of four genetic and four epigenetic loci was trained on the training set and subsequently evaluated on the test set. The test sensitivity and specificity were 0.70 and 0.74, respectively. In contrast, the Framingham risk score and atherosclerotic cardiovascular disease (ASCVD) risk estimator performed with test sensitivities of 0.20 and 0.38, respectively. Notably, the integrated genetic-epigenetic model predicted risk better for both genders and very well in the three-year risk prediction window. We describe a novel DNA-based precision medicine tool capable of capturing the complex genetic and environmental relationships that contribute to the risk of CHD, and being mapped to actionable risk factors that may be leveraged to guide risk modification efforts. |
format | Online Article Text |
id | pubmed-6315411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63154112019-01-09 Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning Dogan, Meeshanthini V. Beach, Steven R. H. Simons, Ronald L. Lendasse, Amaury Penaluna, Brandan Philibert, Robert A. Genes (Basel) Article An improved approach for predicting the risk for incident coronary heart disease (CHD) could lead to substantial improvements in cardiovascular health. Previously, we have shown that genetic and epigenetic loci could predict CHD status more sensitively than conventional risk factors. Herein, we examine whether similar machine learning approaches could be used to develop a similar panel for predicting incident CHD. Training and test sets consisted of 1180 and 524 individuals, respectively. Data mining techniques were employed to mine for predictive biosignatures in the training set. An ensemble of Random Forest models consisting of four genetic and four epigenetic loci was trained on the training set and subsequently evaluated on the test set. The test sensitivity and specificity were 0.70 and 0.74, respectively. In contrast, the Framingham risk score and atherosclerotic cardiovascular disease (ASCVD) risk estimator performed with test sensitivities of 0.20 and 0.38, respectively. Notably, the integrated genetic-epigenetic model predicted risk better for both genders and very well in the three-year risk prediction window. We describe a novel DNA-based precision medicine tool capable of capturing the complex genetic and environmental relationships that contribute to the risk of CHD, and being mapped to actionable risk factors that may be leveraged to guide risk modification efforts. MDPI 2018-12-18 /pmc/articles/PMC6315411/ /pubmed/30567402 http://dx.doi.org/10.3390/genes9120641 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dogan, Meeshanthini V. Beach, Steven R. H. Simons, Ronald L. Lendasse, Amaury Penaluna, Brandan Philibert, Robert A. Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning |
title | Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning |
title_full | Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning |
title_fullStr | Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning |
title_full_unstemmed | Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning |
title_short | Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning |
title_sort | blood-based biomarkers for predicting the risk for five-year incident coronary heart disease in the framingham heart study via machine learning |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315411/ https://www.ncbi.nlm.nih.gov/pubmed/30567402 http://dx.doi.org/10.3390/genes9120641 |
work_keys_str_mv | AT doganmeeshanthiniv bloodbasedbiomarkersforpredictingtheriskforfiveyearincidentcoronaryheartdiseaseintheframinghamheartstudyviamachinelearning AT beachstevenrh bloodbasedbiomarkersforpredictingtheriskforfiveyearincidentcoronaryheartdiseaseintheframinghamheartstudyviamachinelearning AT simonsronaldl bloodbasedbiomarkersforpredictingtheriskforfiveyearincidentcoronaryheartdiseaseintheframinghamheartstudyviamachinelearning AT lendasseamaury bloodbasedbiomarkersforpredictingtheriskforfiveyearincidentcoronaryheartdiseaseintheframinghamheartstudyviamachinelearning AT penalunabrandan bloodbasedbiomarkersforpredictingtheriskforfiveyearincidentcoronaryheartdiseaseintheframinghamheartstudyviamachinelearning AT philibertroberta bloodbasedbiomarkersforpredictingtheriskforfiveyearincidentcoronaryheartdiseaseintheframinghamheartstudyviamachinelearning |